Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
Clinical trial NCT04564742 · COMPLETED
Trial details
- NCT number
- NCT04564742
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2023-07-05
- Enrollment
- 4017
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.